Home › Compare › SQZ vs MCD

SQZ vs MCD: Dividend Comparison 2026

SQZ yields 459.77% · MCD yields 2.35%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 SQZ wins by $32296.75M in total portfolio value
10 years
SQZ
SQZ
● Live price
459.77%
Share price
$0.44
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$32296.82M
Annual income
$22,619,113,625.24
Full SQZ calculator →
MCD
McDonald's Corporation
● Live price
2.35%
Share price
$308.53
Annual div
$7.26
5Y div CAGR
42.3%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$78.5K
Annual income
$26,227.70
Full MCD calculator →

Portfolio growth — SQZ vs MCD

📍 SQZ pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodSQZMCD
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, SQZ + MCD cover 0 of 12 months — good coverage

Jan
—
Feb
—
Mar
—
Apr
—
May
—
Jun
—
Jul
—
Aug
—
Sep
—
Oct
—
Nov
—
Dec
—
SQZ pays
MCD pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

SQZ
Annual income on $10K today (after 15% tax)
$39,080.46/yr
After 10yr DRIP, annual income (after tax)
$19,226,246,581.45/yr
MCD
Annual income on $10K today (after 15% tax)
$200.01/yr
After 10yr DRIP, annual income (after tax)
$22,293.55/yr
At 15% tax rate, SQZ beats the other by $19,226,224,287.91/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of SQZ + MCD for your $10,000?

SQZ: 50%MCD: 50%
100% MCD50/50100% SQZ
Portfolio after 10yr
$16148.45M
Annual income
$11,309,569,926.47/yr
Blended yield
70.04%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MCD right now

SQZ
No analyst data
MCD
Analyst Ratings
37
Buy
23
Hold
1
Sell
Consensus: Buy
Price Target
$351.76
+14.0% upside vs current
Range: $320.00 — $385.00
Altman Z
4.9
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

SQZ buys
0
MCD buys
0
No recent congressional trades found for SQZ or MCD in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricSQZMCD
Forward yield459.77% ✓2.35%
Annual dividend / share$2.00$7.26 ✓
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%42.3% ✓
Portfolio after 10y$32296.82M ✓$78.5K
Annual income after 10y$22,619,113,625.24 ✓$26,227.70
Total dividends collected$31438.26M ✓$58.5K
Payment frequencyquarterlyquarterly
SectorStockConsumer Discretionary

Year-by-year: SQZ vs MCD ($10,000, DRIP)

YearSQZ PortfolioSQZ Income/yrMCD PortfolioMCD Income/yrGap
1← crossover$56,677$45,977.01$10,815$334.85+$45.9K → SQZ
2$304,181$243,536.41$11,826$491.71+$292.4K → SQZ
3$1,547,006$1,221,532.43$13,123$730.06+$1.53M → SQZ
4$7,461,354$5,806,058.08$14,853$1,100.07+$7.45M → SQZ
5$34,154,829$26,171,179.52$17,257$1,690.61+$34.14M → SQZ
6$148,508,521$111,962,854.47$20,752$2,667.01+$148.49M → SQZ
7$613,881,121$454,977,003.60$26,103$4,354.83+$613.86M → SQZ
8$2,414,527,788$1,757,674,987.75$34,794$7,437.78+$2414.49M → SQZ
9$9,044,589,126$6,461,044,393.43$49,926$13,461.60+$9044.54M → SQZ
10$32,296,823,990$22,619,113,625.24$78,550$26,227.70+$32296.75M → SQZ

SQZ vs MCD: Complete Analysis 2026

SQZ — Stock

SQZ Biotechnologies Company, a clinical-stage biotechnology company, develops cell therapies for patients with cancer, autoimmune, infectious diseases, and other serious conditions. Its lead product candidate is SQZ-PBMC-HPV, from its SQZ Antigen Presenting Cells platform, which is in a Phase I clinical trial as a monotherapy and in combination with other immuno-oncology agents for the treatment of HPV16+ advanced or metastatic solid tumors, including cervical, head-and-neck, anal, penile, vulvar, and vaginal cancer. The company also develops SQZ-AAC-HPV, which is in a Phase I clinical trial for the treatment of HPV16+ advanced or metastatic solid tumors in monotherapy and in combinations with other immune-oncology agents. Its additional platforms in development are SQZ Activating Antigen Carriers; and SQZ Tolerizing Antigen Carriers. SQZ Biotechnologies Company was incorporated in 2013 and is headquartered in Watertown, Massachusetts.

Full SQZ Calculator →

MCD — Consumer Discretionary

McDonald's Corporation operates and franchises McDonald's restaurants in the United States and internationally. Its restaurants offer hamburgers and cheeseburgers, chicken sandwiches and nuggets, wraps, fries, salads, oatmeal, shakes, desserts, sundaes, soft serve cones, bakery items, soft drinks, coffee, and beverages and other beverages, as well as breakfast menu, including biscuit and bagel sandwiches, breakfast burritos, hotcakes, and other sandwiches. As of December 31, 2021, the company operated 40,031 restaurants. McDonald's Corporation was founded in 1940 and is headquartered in Chicago, Illinois.

Full MCD Calculator →
📬

Get this SQZ vs MCD comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

SQZ vs SCHDSQZ vs JEPISQZ vs OSQZ vs KOSQZ vs MAINSQZ vs YUMSQZ vs QSRSQZ vs SBUX

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.